Sydney Freedberg

Chief reporter @ICIJ, author, Pulitzer Prize winner. Tips [email protected]

[Luca Evans @bylucaevans]

#Warriors guard De’Anthony Melton said GSW’s defense will have “teeth” under Frank Vogel.

Said at media day Golden State’s goal is to have a top-3 defense. Asked him why that’s a realistic goal.

“We got more size at positions that we needed it.”

More: “We got to punch first.”

[Sydney Freedberg @spfreedberg]

@CPJAfrica We’d like to make an urgent call for the immediate safe return of our colleague, Micah Reddy, and his fixer, Kooki Mahmoud, who have been missing in Djibouti for more than 24 hours. We need a transparent investigation, and emphasize the vital role of press freedom.

[Sydney Freedberg @spfreedberg]

This cancer drug is saving lives. It’s also threatening to break Canadian healthcare budgets.

https://t.co/WNOFvxAWSH

[ProjectCJEGC @ProjectCJEGC]

A review by ICIJ found cancer drug makers have paid over $1.7 billion in settlements and fines over a 15-year period. But those payments often make up less than 1% of their revenues – and experts said many companies see them as the cost of doing business. https://t.co/ZR9Po1fqiA

[Sydney Freedberg @spfreedberg]

@BenMullin So sad to hear this. Grieving for Miami and my beloved Herald.

[Peter Schorsch @PeterSchorschFL]

IT'S NOT THE REPORTERS FAULT the @MiamiHerald is dying.

IT'S THE SHITTY BUSINESS (NON) LEADERS.

The site is a dog's breakfast. Cringe-y pop-up ad upon arrival. Spammy links everywhere.

And most of the @McClatchy sites are like this.

[Ida B. Wells Society @IBWellsSociety]

An ICIJ review found nearly $1.7 billion in settlements and fines over a 15 year period. But experts said many companies see the payouts as the cost of doing business.

https://t.co/PWDnqPDPqD

[ICIJ @ICIJorg]

A US Senator has written to pharma giant Merck, citing ICIJ's #CancerCalculus investigation and expressing concerns about anti-competitive practices and sky-high prices of the company's flagship cancer drug Keytruda.
https://t.co/xf9uGNTEeK

[ICIJ @ICIJorg]

In a yearlong investigation led by ICIJ, reporters from more than 37 countries found Keytruda’s high price impacts patients and health systems differently, from Finland to Brazil, India, Malta, Mexico and beyond.

Read the stories: https://t.co/EVcS3QfKAG

[GIJN en Español @gijnEs]

🇬🇹 Este reportaje de @PlazaPublicaGT, que forma parte de un especial de @ICIJorg, sigue las historias de pacientes guatemaltecos con cáncer que luchan por acceder a Keytruda, un medicamento innovador pero extremadamente costoso. https://t.co/fiBBf4atsi

[Sydney Freedberg @spfreedberg]

Brazilian Supreme Court Justice criticizes excess pharma lawsuits, health care inequities #CancerCalculus

https://t.co/I4o7Ig4BEr

[ICIJ @ICIJorg]

ICIJ's upcoming live panel will explore how Keytruda became a case study in the global tension between medical innovation, pharmaceutical profits and equitable access to care.

Sign up to learn from #CancerCalculus lead reporter Sydney Freedberg: https://t.co/tV3PTSDVxV

[Stefan Melichar @StefanMelichar]

1. Station unserer IFG-Transparenz-Tour zum Krebsmittel „Keytruda“: Salzburg. Bin um 3.30 Uhr auf, um pünktlich um 9 am LVwG zu verhandeln. Nicht erschienen: der Landesspitalsbetreiber, der wichtige Infos verweigert. #CancerCalculus @profilonline @ICIJorg https://t.co/pQJju63knF

[Fight For A Living Wage @Fight4Wage]

This episode is about Keytruda; we pay significantly more for Keytruda than any other country. What happened to big pharma agreeing to lower drug costs?
@usatoday
It's about an 11 minute listen, "The blockbuster cancer drug Keytruda can cost over $150,000"
https://t.co/u9kuRbvTSD

[Reporters United @reporters_gr]

#Thread: Νέα δημοσίευση.

❗Ο πρόεδρος του #Eurogroup στο σπίτι της πρέσβειρας του #Τραμπ.

🔸Σιωπή #Πιερρακάκη για την παραθεσμική παρουσία του στην οικία #Γκιλφόιλ με φόντο τα #φάρμακα.

🤝 @ICIJorg
✍️ @dpapageorgiou26 @boublis
✒️ @KasdaglisC @Chondrogiannos
🎨 @spoovio

[Sydney Freedberg @spfreedberg]

The man who secured the Poynter Institute’s ownership of the Tampa Bay Times and his own legacy. RIP, Andy Barnes

[Poynter @Poynter]

Former Poynter chairman and Tampa Bay Times CEO Andrew Barnes died Thursday at the age of 86. He leaves behind a wife, Molly, and three children, Chris, Ben and Elizabeth.

During the more than 50 years Barnes worked in journalism, he helped lead the St. Petersburg Times, now the Tampa Bay Times, to multiple Pulitzer Prizes and greatly expanded and modernized the Poynter Institute. But perhaps his most significant contribution was shepherding the institute through an attempted hostile takeover of the Times, ensuring that the paper would remain independently owned.

Read more: https://t.co/jfdu8Td5Yr

[Sydney Freedberg @spfreedberg]

‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation - ICIJ https://t.co/kYjKIV5Ilh

[ICIJ @ICIJorg]

ICIJ's #CancerCalculus investigation brought together reporters worldwide to shed new light on strategies Merck & Co. has used to widen the use of its blockbuster cancer drug and protect its monopoly.

Here are some of the stories from our media partners: https://t.co/EVcS3QfKAG

[Indian Pharma Post @indpharmapost]

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

https://t.co/xlyaiFtsE1

#Merck #USFDA #KEYTRUDA #bladdercancer

@indpharmapost

[Scrip, Citeline Commercial @PharmaScrip]

Top 10 Drugs 2025: Keytruda Holds The Crown, But Tirzepatide Is Coming — Click image below to read more! || #Scrip | Start your free trial today: https://t.co/JUoN06HunA https://t.co/v430dsEjB5